Upward Momentum: Weight Watchers Intl (WTW), Helix Energy Solutions Group (HLX)


The price of the stock of Weight Watchers International, Inc. (NYSE:WTW) soared for second day in a raw, continuing the positive momentum generated by Oprah Winfrey’s $43 million investment for a 10% equity stake in the company

Investment analysts at Barclays upgraded shares of Weight Watchers from an Underweight to an Equal Weight rating and raised their price target on the company’s stock from $5.00 to $14.00

WTW stock closed at $18.24, up $4.32 (or +31.03%), with a total volume of 68,128,919 shares traded on Tuesday, a huge increase in activity versus its average volume (3m) of a very large increase in activity

Weight Watchers International, which provides weight management services worldwide, has 57.21M Shares Outstanding, Market Capitalization (intraday) of $1.04B and WTW stock 52-week range is between $3.67 and $29.84 per share



Helix Energy Solutions Group, Inc. (NYSE:HLX) shares climbed $1.37 (or +26.50%) to $6.54 on Tuesday’s trading session after the company delivered quarterly profit above Wall Street analysts’ expectations

For the third quarter 2015, Helix Energy posted revenues of $182.5 million and net income of $9.9 million, or $0.09 per diluted share, surpassing the Capital IQ Consensus Estimate of $0.07 earnigs per share for the period

9,389,743 shares of the company were traded during the day

Helix Energy Solutions Group, an international offshore energy services company, has 105.96M Shares Outstanding, Market Capitalization (intraday) of $692.98M and HLX stock one-year range is $4.57 – $27.70 per share


Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. GalaxyStocks is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://galaxystocks.com/disclaimer/